Mirati Therapeutics Inc (MRTX)

[swampboots]

I bought enough to match my stake based on the superficial knowledge that the price fall into the nines were over wrought
based on price decline reacting to the adverse side effects which were not lethal. Side effects always occur in these risky treatments for unmet treatments.

Ok now I am looking closer and notice treatment with Tyrosine kinase inhibitors "(TKIs) have been approved for the treatment of various cancers driven by kinase oncogenes such as EGF receptors, ALK, KIT and BCR-ABL1."

Yet all kinds of factors influencing the up take and the outcomes, and other drugs being tested by other drug Co.s to combine with use of the TKI's...
so years before final failure could be declared.

Bottom line: MRTX's TKI a work in progress platform is in its infancy
but there is scientific evidence of the general TKI effectiveness in some form, targeting some type of receptor, that has probable likelihoods of being represented in some final form, at some date, at some expense..

Some remarks about TKI's here:
http://www.nature.com/articles/srep29559